|
|
||||||||
The FASEB Journal, Vol 8, 1081-1087, Copyright © 1994 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
WY Lee, MF Lockniskar and SM Fischer
Division of Pharmacology/Toxicology, College of Pharmacy, University of Texas at Austin 78712.
The topical application of the tumor promoter 12-O-tetradecanoylphorbol- 13-acetate (TPA) to murine skin produces acute inflammatory and hyperplastic responses that have been associated with the promotion stage of skin carcinogenesis. It has been shown in a previous study that TPA induces the expression of the highly inflammatory cytokine, interleukin (IL) -1 alpha, in the epidermis of SENCAR mice. The goal of this study was to investigate the role of IL-1 alpha in several TPA- induced responses in skin. Topical application of TPA (1 microgram) enhanced the production of immunoreactive IL-1 alpha protein, primarily associated with the suprabasal keratinocytes. IL-1 alpha intradermally injected in the dorsal surface significantly increased (P < 0.001) vascular permeability at low concentrations (1-1000 microU) and increased (P < 0.001) inflammatory cell infiltration and epidermal hyperplasia at higher concentrations (10(3) U). TPA produced fourfold increases in vascular permeability as measured by Evans blue dye leakage; this effect was prevented by intradermal injection of anti-IL- 1 alpha antibody (25-75 micrograms). Furthermore, injected anti-IL-1 alpha antibody significantly reduced (P < 0.001) TPA-induced inflammatory cell infiltration and epidermal hyperplasia. This study suggests that IL-1 alpha directly or indirectly mediates the inflammatory and hyperplastic responses elicited by topical treatment with TPA.
This article has been cited by other articles:
![]() |
S. Ikuta, H. Edamatsu, M. Li, L. Hu, and T. Kataoka Crucial Role of Phospholipase C{varepsilon} in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester Cancer Res., January 1, 2008; 68(1): 64 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, J. Eckard, R. Shah, C. Malluck, and K. Frenkel Interleukin-1{alpha} Up-Regulation in Vivo by a Potent Carcinogen 7,12-Dimethylbenz(a)anthracene (DMBA) and Control of DMBA-induced Inflammatory Responses Cancer Res., January 1, 2002; 62(2): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Arsenijevic, L. Girardier, J. Seydoux, J. C. Pechere, I. Garcia, R. Lucas, H. R. Chang, and A. G. Dulloo Metabolic-cytokine responses to a second immunological challenge with LPS in mice with T. gondii infection Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E439 - E445. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rauschmayr, R. W. Groves, and T. S. Kupper Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation PNAS, May 27, 1997; 94(11): 5814 - 5819. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |